Results 221 to 230 of about 5,994,707 (387)

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham   +21 more
wiley   +1 more source

Promiscuity and specificity in ligand sensing by plant cell surface receptors. [PDF]

open access: yesPLoS Pathog
Steidele CE   +4 more
europepmc   +1 more source

The RXR heterodimers and orphan receptors

open access: yesCell, 1995
D. Mangelsdorf, R. Evans
semanticscholar   +1 more source

Decrypting cancer's spatial code: from single cells to tissue niches

open access: yesMolecular Oncology, EarlyView.
Spatial transcriptomics maps gene activity across tissues, offering powerful insights into how cancer cells are organised, switch states and interact with their surroundings. This review outlines emerging computational, artificial intelligence (AI) and geospatial approaches to define cell states, uncover tumour niches and integrate spatial data with ...
Cenk Celik   +4 more
wiley   +1 more source

Identification of a G Protein-Coupled Receptor for Buccalin-Type Peptides in the Mollusk <i>Aplysia</i>: Evolutionary Insights into Neuropeptide Signaling. [PDF]

open access: yesACS Omega
Xu JP   +16 more
europepmc   +1 more source

Evidence for a central 5‐hydroxytryptamine receptor stimulation by lysergic acid diethylamide [PDF]

open access: green, 1968
N.‐E. Andén   +3 more
openalex   +1 more source

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

open access: yesMolecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy